Boehringer Ingelheim and the quest for the golden batch

3 Pages

Boehringer Ingelheim sought to understand variations in biological batch processes to achieve consistent, high-quality production. By employing the AVEVA PI System to enable multivariate data analysis and attribute data management, they reduced production variance, increased batch potency, minimized batch destruction, and improved yield. This solution supports their quest for the "golden batch," optimizing pharmaceutical manufacturing processes for greater efficiency and reliability, demonstrating AVEVA’s critical role in enhancing biopharmaceutical production outcomes.

Join for free to read

Case Study Boehringer Ingelheim

Case Study Boehringer Ingelheim France

Case Study Uwe Waldschmidt; Boehringer Ingelheim

More from AVEVA

Case Study Bristol-Myers Squibb: Using real-time multivariate analytics to…

White Paper Agility for competitiveness: Transforming manufacturing…

White Paper The four pillars of a trusted industrial information…

White Paper The business case for digital transformation

Case Study

Boehringer Ingelheim and the quest for the golden batch

Boehringer Ingelheim and the quest for the golden batch

You Might Also Like

More from AVEVA